<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00124</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=81 g=1 f=1 --> 2. Control of RSV Outbreaks  <!-- PJG 0012 frnewline --> a. Use of Private Room, Cohorting, and Patient-Screening  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> To control ongoing RSV transmission in the hospital, admit young children with symptoms of viral respiratory illness to single rooms when possible, OR perform RSV-screening diagnostic tests on young children upon admission and cohort them according to their RSV-infection status. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 543,545,547,549 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY II  <!-- PJG 0012 frnewline --> b. Personnel Cohorting  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> During an outbreak of nosocomial RSV, cohort personnel as much as practical, i.e., restrict personnel who give care to infected patients from giving care to uninfected patients, and vice-versa. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 543,547,549 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY II  <!-- PJG 0012 frnewline --> c. Postponing Patient Admission  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> During outbreaks of nosocomial RSV, postpone elective admission of uninfected patients at high risk of complications from RSV infection.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY II  <!-- PJG 0012 frnewline --> d. Wearing Eye-Nose Goggles  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> NO RECOMMENDATION for wearing eye-nose goggles for close contact with an RSV-infected patient. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 546,550 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> UNRESOLVED ISSUE  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Prevention and Control of Influenza  <!-- PJG 0012 frnewline --> I. Staff Education and Infection Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Staff Education  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Educate personnel about the epidemiology, modes of transmission and means of preventing the spread of influenza. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 611&hyph;613,668,669 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Surveillance  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Establish mechanism(s) by which the appropriate hospital personnel are promptly alerted of any increase in influenza activity in the local community.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Arrange for laboratory tests to be available to clinicians, for use when clinically indicated, to promptly confirm the diagnosis of influenza and other acute viral respiratory illnesses, especially during November-April. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 573&hyph;578 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> II. Modifying Host Risk to Infection  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> A. Vaccination  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> 1. Patients  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Offer vaccine to outpatients and inpatients at high risk of complications from influenza, beginning in September and continuing until influenza activity has begun to decline. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 581,584,603,670&hyph;672 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Patients at high risk of complications from influenza include those "65 years of age; in long-term-care units; with chronic disorders of the pulmonary or cardiovascular systems, diabetes mellitus, renal dysfunction, hemoglobinopathies, musculo-skeletal disorders that impede adequate respiration, or immunosuppression; and children 6 months-18 years of age who are receiving long-term aspirin therapy. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 581 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IA  <!-- PJG 0012 frnewline --> 2. Personnel  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Vaccinate healthcare workers before the influenza season each year, preferably between mid-October and mid-November. Until influenza activity declines, continue to make vaccine available to newly hired personnel and to those who initially refuse vaccination. If vaccine supply is limited, give highest priority to staff caring for patients at greatest risk of severe complications from influenza infection, as listed in Section II-A&hyph;1 above. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 581 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=83 g=1 f=1 --> B. Use of Antiviral Agents (See Section IV Below, Control of Influenza Outbreaks)  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> III. Interruption of (Person-to-Person) Transmission  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> A. Keep a patient for whom influenza is suspected or diagnosed in a private room, or in a room with other patients with proven influenza, unless there are medical contraindications to do so.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=81 g=1 f=1 --> CATEGORY IB  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> B. As much as feasible, maintain negative air pressure in rooms of patients for whom influenza is suspected or diagnosed, or place together persons with influenza-like illness in a hospital area with an independent air-supply-and-exhaust system. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 566,567,569,673 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            